Concepedia

Nigel J. Liverton

NJ

59

Publications

3.4K

Citations

31

H-Index

1985

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Cornell University

Tri-Institutional Therapeutics Discovery Institute

IRBM Science Park

Nigel J. Liverton is an author at United States Military Academy specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1985–2024

59

Publications

59

Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor

James E. Thompson, Rose M. Cubbon, Richard Cummings et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 265 citations · Full text

, , +7

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

, , +19

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

Nigel J. Liverton, John W. Butcher, Christopher F. Claiborne et al. · Journal of Medicinal Chemistry · 1999 · 196 citations · Full text

, , +17

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

John A. McCauley, Charles McIntyre, Michael T. Rudd et al. · Journal of Medicinal Chemistry · 2010 · 176 citations

, , +17

Rows per page

1–5 of 59